Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda

被引:148
作者
Whalen, CC
Nsubuga, P
Okwera, A
Johnson, JL
Hom, DL
Michael, NL
Mugerwa, RD
Ellner, JJ
机构
[1] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA
[3] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda
[4] Uganda Minist Hlth, Natl TB & Leprosy Control Programme, Kampala, Uganda
[5] Walter Reed Army Inst Res, Div Retrovirol, Rockville, MD USA
关键词
HIV-1; tuberculosis; survival; Africa; prospective cohort study;
D O I
10.1097/00002030-200006160-00020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Retrospective cohort studies of tuberculosis suggest that active tuberculosis accelerates the progression of HIV infection. The validity of these findings has been questioned because of their retrospective design, -diverse study populations, variable compliance with anti-tuberculous therapy and use of anti-retroviral medication. To assess the impact of tuberculosis on survival in HIV infection we performed a prospective study among HIV-infected Ugandan adults with and without tuberculosis. Methods: In a prospective cohort study, 230 patients with HIV-associated tuberculosis and 442 HIV-infected subjects without tuberculosis were followed for a mean duration of 19 months for survival. To assess changes in viral load over 1 year, 20 pairs of tuberculosis cases and controls were selected and matched according to baseline CD4 lymphocyte count, age, sex and tuberculin skin test status. Results: During the follow-up period, 63 out of of 230 tuberculosis cases (28%) died compared with 85 out of 442 controls (19%), with a crude risk ratio of 1.4 [95% confidence interval (CI), 1.07-1.87]. Most deaths occurred in patients with CD4 lymphocyte counts < 200 x 10(6) cells/l at baseline (n = 99) and occurred with similar frequency in the tuberculosis cases (46%) and the controls (44%). When the CD4 lymphocyte count was > 200 x 10(6) /l, however, the relative risk of death in HIV-associated tuberculosis was 2.1 (195% CI, 1.27-3.62) compared with subjects without tuberculosis. For subjects with a CD4 lymphocyte count > 200 X 10(6)/l, the 1-year survival proportion was slightly lower in the cases than in the controls (0.91 versus 0.96), but by 2 years the survival proportion was significantly lower in the cases than in the controls (0.84 versus 0.91; P<0.02; log-rank test). For subjects with a CD4 lymphocyte count of 200 x 10(6) cells/l or fewer, the survival proportion at 1 year for the controls was lower than cases (0.59 versus 0.64), but this difference was not statistically significant (P = 0.53; logrank test). After adjusting for age, sex, tuberculin skin test status, CD4 lymphocyte count, and history of HIV-related infections, the overall relative hazard for death associated with tuberculosis was 1.81 (95% CI, 1.24-2.65). In a nested Cox regression model, the relative hazard for death was 3.0 (95% CI, 1.62-5.63) for subjects with CD4 lymphocyte counts > 200 x 10(6)/l and 1.5 (95% CI, 0.99-2.40) for subjects with a CD4 lymphocyte count of 200 x 10(6)/l or fewer. Conclusion: The findings from this prospective study indicate that active tuberculosis exerts its greatest effect on survival in the early stages of HIV infection, when there is a reserve capacity of the host immune response. These observations provide a theoretical basis for the treatment of latent tuberculous infection in HIV-infected persons. (C) 2000 Lippincott Williams & Wilkins .
引用
收藏
页码:1219 / 1228
页数:10
相关论文
共 41 条
[1]   RESPONSE TO TREATMENT, MORTALITY, AND CD4 LYMPHOCYTE COUNTS IN HIV-INFECTED PERSONS WITH TUBERCULOSIS IN ABIDJAN, COTE-DIVOIRE [J].
ACKAH, AN ;
COULIBALY, D ;
DIGBEU, H ;
DIALLO, K ;
VETTER, KM ;
COULIBALY, IM ;
GREENBERG, AE ;
DECOCK, KM .
LANCET, 1995, 345 (8950) :607-610
[2]   Selective increase in plasma tumor necrosis factor-α and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis [J].
Bekker, LG ;
Maartens, G ;
Steyn, L ;
Kaplan, G .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02) :580-584
[3]   AN OUTBREAK OF TUBERCULOSIS WITH ACCELERATED PROGRESSION AMONG PERSONS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS - AN ANALYSIS USING RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS [J].
DALEY, CL ;
SMALL, PM ;
SCHECTER, GF ;
SCHOOLNIK, GK ;
MCADAM, RA ;
JACOBS, WR ;
HOPEWELL, PC .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (04) :231-235
[4]   Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology [J].
Del Amo, J ;
Malin, AS ;
Pozniak, A ;
De Cock, KM .
AIDS, 1999, 13 (10) :1151-1158
[5]   Spectrum of disease in Africans with AIDS in London [J].
DelAmo, J ;
Petruckevitch, A ;
Phillips, AN ;
Johson, AM ;
Stephenson, JM ;
Desmond, N ;
Hanscheid, T ;
Low, N ;
Newell, A ;
Obasi, A ;
Paine, K ;
Pym, A ;
Theodore, CM ;
DeCock, KM .
AIDS, 1996, 10 (13) :1563-1569
[6]   Host factors and the pathogenesis of HIV-induced disease [J].
Fauci, AS .
NATURE, 1996, 384 (6609) :529-534
[7]   The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous interleukin-2 and proinflammatory and antiinflammatory cytokines [J].
Goletti, D ;
Weissman, D ;
Jackson, RW ;
Collins, F ;
Kinter, A ;
Fauci, AS .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) :1332-1338
[8]  
Goletti D, 1996, J IMMUNOL, V157, P1271
[9]  
GOLETTI D, 1996, 3 C RETR OPP INF WAS
[10]  
International Union Against Tuberculosis and Lung Disease, 1986, B INT UNION TUBER S2, V61, P1